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hBMSCs before, that the sheets were shrunk under the serum-free
chondrogenic medium, but not under the serum mixed chondrogenic
medium. Moreover, other groups have shown the addition of basic
ﬁbroblast growth factor (bFGF) during expansion phase enhanced not
only their proliferation, but also their chondrogenic capacity of hBMSCs
with chondrogenic pellet culture system after their expansion. This
modiﬁcation during expansionphasemight be applied to the cell-sheets.
The aim of this study is to investigate better condition to provide stably
and securely the scaffold-free cartilage-like cell-sheets from hBMSCs.
Methods: The hBMSCs were harvested from bone marrow obtained by
routin iliac crest aspiration from 3 young male volunteers (21yo, 27yo,
and 31yo) with their agreement before lower extremity joint surgeries.
The proliferative and chodrogenic capacity were assessed at P1 stage.
hBMSCs were expanded with DMEM-LG containing 1% Penicillin/
Streptomycin, condition (1)5%FBS, condition (2)10%FBS, or condition (3)
5%FBS with 10ng/ml of bFGF, in monolayer culture. The proliferation
rate was determined from hemocytometer counts. Then, the cells har-
vested from the cultivation under (1), (2), and (3) were applied to v-
shaped non-adherent 96-well plate at 250,000 cells per well to perform
chondrogenic pellet culture system for 21 days. Chondrogenic differ-
entiation medium consisting of DMEM-HG with 1% ITS-premix, 10 nM
Dexamethasone,130uM ascorbate-2-phosphate,1% sodium pyruvate,1%
Penicillin/Streptomycin and 10ng/ml TGFb1 was employed for the pel-
let, and changed freshly every other day. The glycosaminoglycan (GAG)
contents of each pellet were measured and normalized with DNA (GAG/
DNA) to evaluate their chondrogenic differentiation capacity. Moreover,
the BMSCs from one donor (21yo) were expanded under the condition
(3)5%FBS with 10ng/ml of bFGF, until P3 stage to fabricate scaffold-free
cartilage-like cell-sheets with cell culture inserts (CCIs: 0.3 cm^2,
thickness, 20-25mm, polyethylene terephthalate). The sheets were
generated with condition (A) serum-free chodrogenic differentiation
medium alone or condition (B) equal mixture of serum-free chondro-
genic medium and growth medium with 10% FBS, condition(2), for 21
days. The pellets and cell-sheets were ﬁxed with 10% formalin and
embedded in parafﬁn and they were sectioned and stained with
Safranin O/Fast Green.
Results: The proliferation rates of condition(2) were 2 times higher
than (1) (p < 0.05) and (3) were 4.5 times higher than (1) (p < 0.001).
The difference between GAG/DNA of (1) and (2) was not signiﬁcant, but
that of (3) was 3 times higher than others (p< 0.05). Safranin-O staining
(3) was stained well compared (1), and (2). The cell-sheets, neither
under (A) and (B) were not shrunk nor detached from the inside wall of
CCIs, but once taken from CCIs, the sheets under (A) looked shrunk and
the edge was curling (Figure). The intensity of the Safranin-O staining
showed no difference between (A) and (B). The shape of the edge of the
(A) had curled thickening compared with (B). That of (B) was ﬂat.
Conclusion: The proliferative and chodrogenic capacity of hBMSCs
were enhanced by bFGF during expansion phase only, even if the serum
concentration was reduced. This condition might be useful to yield
much cells fast enough and to provide stably and securely the scaffold-
free cartilage-like cell-sheets.
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Purpose: Current treatment options for osteoarthritis (OA) aim to
reduce pain and improve joint functioning. However, focal cartilagedamage due to trauma predisposes the onset of OA. Use of scaffolds is a
good strategy for the treatment of these small lesions. In the past,
various synthetic and natural proteins have been described for their use
as scaffolding material for tissue engineering. However, all of these
scaffolds have advantages and disadvantages in terms of the biological
compatibility, strength, elasticity and durability of the material. The
perfect scaffolding material for articular cartilage has not been found.
We propose a new strategy for generation of cartilage scaffold material.
Many proteins and peptides can self-assemble into b-sheet rich amyloid
ﬁbrils. The resulting ﬁbrils are up to tens of nanometres wide and
several micrometres in length, and can cluster into large aggregates. As
scaffolding material, these amyloid ﬁbrils have interesting character-
istics for the generation of cartilage tissue: their mechanical properties
are comparable to collagen ﬁbres, they are degradation resistant, they
form hydrogels and can be functionalized. The purpose of this study
was to characterize amyloid ﬁbrils and to investigate the effect of
amyloid structures on bovine chondrocyte viability and metabolic
activity.
Methods: The proteins a-synuclein, b-lactoglobulin and lysozyme self-
assembled into amyloid ﬁbrils. Their formation and resulting structures
were analysed using circular dichroism, Thioﬂavin T ﬂuorescence,
atomic force microscopy (AFM) and scanning electron microscopy
(SEM). Bovine articular cartilage was collected from bovine knees and
chondrocytes were isolated from the cartilage using collagenase 2. The
bovine chondrocytes were cultured in monolayer and in the presence of
amyloid ﬁbrils or aggregates (Figure 1). The viability of the chon-
drocytes was analysed using Calcein AM in combination with ﬂow-
cytometry and the bulk metabolic activity was investigated using MTT.
Changes in gene expression, among others cartilage speciﬁc genes like
SOX9, COL2A1 and ACAN, in the presence of amyloid structures were
analysed using qPCR. In addition, the effect of the amyloid ﬁbrils on cell
viability and metabolism was investigated using different amyloid
concentrations and incubation times.
Results: SEM imaging conﬁrmed the formation of ﬁbrils. AFM imaging
conﬁrmed the formation of ﬁbrils and showed different morphologies
and heights depending on the different proteins used to form amyloid
ﬁbrils. Results indicate that the presence of a-synuclein amyloid
aggregates has no negative effects on cell viability or metabolic activity
after one week in culture. Cartilage marker gene expression went down
after culturing for one week in presence or absence of amyloid aggre-
gates, indicating that the presence of amyloid aggregates did not have
an effect on the cartilage gene speciﬁc gene expression. Finally, bovine
chondrocyte proliferation appears to increase in the presence of the
aggregates.
Conclusions: The results indicate that the different proteins can form
amyloid ﬁbrils with different morphologies and heights. In addition, a-
synuclein amyloid aggregates do not appear to inﬂuence cell viability
and cartilage gene expression. The gradual loss of articular cartilage
genes was probably due to dedifferentiation of the chondrocytes in a
monolayer culture. The effect of morphological differences between the
ﬁbrils and aggregates generated from different proteins on the cell
viability and metabolic activity will be investigated in more detail. The
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S489results indicate that the amyloid structures could potentially be used for
cartilage tissue engineering. The next steps include culturing chon-
drocytes with amyloid structures in a 3D hydrogel to provide a more
realistic surrounding to the cells and to preserve the chondrocyte
phenotype. Microscopy image of bovine chondrocytes (dark) in culture
with a-synuclein amyloid aggregates (transparent). The dark color of
the cells is caused by formazan crystals as a result of the MTT assay.
Scale bar represent 100 mm.
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Purpose: Our laboratory has adopted a chondrocyte-seeded collagen
sponge system for tissue-engineering of cartilage. We have recently
developed an efﬁcient procedure to amplify human chondrocytes in
culture with a cocktail of ﬁbroblast growth factor (FGF)-2 and insulin
(FI). This cocktail allows the ampliﬁed chondrocytes to build a cartilage
matrix in collagen scaffolds, in the presence of bone morphogenetic
protein (BMP)-2, insulin and triiodothyronine (BIT). Here, we inves-
tigated if the dog model can be used to test in vivo implantation of the
cartilage construct for resurfacing articular cartilage defects.
Methods: Osteochondral blocks were harvested from cadavers of
skeletally mature male beagle dogs. Lateral and medial femoral con-
dyles (weight bearing sites) and femoral trochlea (non weight bearing
site) were processed for immunohistochemical analyses. Several pri-
mary antibodies against collagen proteins were screened on tissue
sections, with particular attention given to their ability to speciﬁcally
recognize collagen molecules characteristic of cartilage (type II colla-
gen) or bone and ﬁbrotic tissues (type I collagen). For in vitro recon-
struction of tissue-engineered cartilage, isolated canine articular
chondrocytes were ampliﬁed with the FI cocktail then cultured for 3
weeks in collagen sponges with the BIT cocktail. The neo-synthesized
matrix was evaluated by Western-blotting and immunohistochemical
analyses.
Results: We selected commercially available human anti-type I and
anti-type II collagen antibodies (Novotec, France) that were able to
discriminate canine type I and type II collagen proteins, as judged by the
mutually exclusive immunohistological stainings of cartilage and bone
by the two antibodies. In addition we developed an original antibody
capable of detecting the IIB form of type II collagen, the unique carti-
lage-speciﬁc isoform of type II collagen. Regarding cartilage recon-
struction in the collagen scaffolds, canine chondrocytes were able to
synthesize large amount of cartilage-characteristic proteins (such as
type II and type IX collagens). Interestingly, our Western-blotting
analysis also indicated that most of the type II collagen produced was
type IIB. Very importantly, our immunohistochemical and Western-
blotting analyses revealed extremely low amounts of type I collagen
production.
Conclusions: The combination of the FI and BIT cocktails during
expansion and culture of adult canine chondrocytes in collagen scaf-
folds led to the formation of cartilage whose biochemical composition
closely resembles to native cartilage. Thus, canine and human chon-
drocytes respond similarly to the FI and BIT cocktails. We have also
shown here that the biochemical quality of the cartilage matrix
reconstructed by canine chondrocytes can be evaluated by the use of
speciﬁc antibodies. The next step will be to test the functional proper-
ties of the tissue-engineered cartilage after implantation in the dog
knee joint. We have selected the adult canine animal model because it
offers several advantages: its clinical relevancewith respect to anatomy,
function, and clinical disorders in veterinary medicine (similar to
humans, dogs lack signiﬁcant intrinsic ability to heal cartilage defects
and suffer from cartilage problems such as osteochondritis dissecansand OA); the ability to perform surgical treatments such as arthroplasty,
chondrocyte transplantation and osteochondral grafting, as well as
postoperative management protocols. These features are important for
future validation and comparison of tissue engineering to the accepted
clinical treatments.
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Purpose: Articular cartilage, is of great importance for physiological
mobility. The structure and the function of this tissue, which is char-
acterized by a poor self-repair capacity, are frequently disrupted or
damaged upon physical trauma or in degenerative osteoarthritis (OA).
Given that musculoskeletal disorders are the leading cause of poor
performance or early retirement of sports and race horses, treating
horses for these disorders is relevant. The proposed therapeutic
approach, which was ﬁrst developed for human, has the potential of
being considered as a pre-clinical step for human medicine because the
horse is recognized as an excellent model for the study of articular
cartilage disorders in humans.
This study aims to improve the Autologous Chondrocytes Implantation
(ACI) technique by using Mesenchymal Stem cells (MSCs) from bone
marrow (easy to collect in horse) as the cell source. Thus, MSCs were,
ﬁrst, characterized before being cultured with chondrogenic conditions
in order to ﬁnd the combination that best enhances and stabilizes the
characteristics of the chondrocyte phenotype, in order to perform
clinical trials in horse.
Methods: MSCs from equine bone marrow were isolated and
expanded in monolayer cultures until 4 passages. These cells were
characterized by analyzing their proliferative potential, their pluri-
potency (with microenvironmental stimuli) and their capacity to
express MSCs speciﬁc phenotypic markers deﬁning the MSCs (ﬂow
cytometry). In parallel, MSCs differentiation in chondrocytes was
accomplished via a combinatory approach based on the association of
3D-culture in type I collagen sponges, low oxygen tension with
chondrogenic factors (BMP-2, TGF-b1) and RNA interference (siRNA to
down-regulate type I collagen and HtrA1 protein expression). Finally,
an extensive analysis at gene and protein levels corresponding to
differentiated, dedifferentiated and hypertrophic chondrocyte pheno-
types was performed.
Results: Our results show a very high proliferation potential of MSCs
isolated from equine bone marrow. Furthermore, the isolated cells
satisfy the various criteria of stem cells deﬁnition (pluripotency,
expression of surface markers). In addition, siRNAs targeting equine
Col1a1 and Htra1 have been functionally validated. Finally, we show
that the BMP-2 and TGF-b1 combination strongly induces the differ-
entiation of MSCs in chondrocytes. Thus, the combined use of speciﬁc
culture conditions deﬁned within the laboratory, with speciﬁc growth
factors and siRNAs association leads to the in vitro synthesis of a hyaline
type neo-cartilage by chondrocytes which present an optimal pheno-
typic index, comparable to the one established with induction of spe-
ciﬁc differentiation of human MSCs in chondrocytes, and close to the
one of differentiated/healthy chondrocytes.
Conclusions: These data represent a ﬁrst step in the development of
equine clinical trials, which are planed - to better understand the
reaction of cartilage tissue after a few weeks of intra-articular implan-
tation and - to make the proof of concept in a large animal model.
This approach will allow us to explore the criteria necessary to begin
to consider the development of cell therapy for cartilage repair in
humans.
